Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventAug 10, 2004View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionAug 9, 2004View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsAug 5, 2004View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsAug 5, 2004View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsAug 5, 2004View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsAug 5, 2004View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KAug 2, 2004View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 29, 2004View HTMLDownload DOCDownload PDF
POS AMPost-effective amendment to an S-Type filingJul 22, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJul 20, 2004View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 12, 2004View HTMLDownload DOCDownload PDF
424B3Form of prospectus reflecting facts events constituting substantive change from last formJun 25, 2004View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formJun 17, 2004View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 15, 2004View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 4, 2004View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 4, 2004View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 2, 2004View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 19, 2004View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4May 14, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 11, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 7, 2004View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-78

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information